- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3685
10-year publication summary
245
|
221
|
293
|
262
|
262
|
293
|
300
|
320
|
349
|
207
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Deciphera Pharmaceuticals, LLC | 223 |
68 |
Novartis AG | 10850 |
59 |
Incyte Corporation | 1024 |
49 |
F. Hoffmann-La Roche AG | 7921 |
43 |
Immunomedics, Inc. | 259 |
42 |
Bristol-myers Squibb Company | 4893 |
41 |
Merck Sharp & Dohme LLC | 3741 |
40 |
Merck Patent GmbH | 5823 |
37 |
Bayer Pharma AG | 1047 |
35 |
Boehringer Ingelheim International GmbH | 4648 |
34 |
Hoffmann-La Roche Inc. | 3422 |
27 |
Gilead Sciences, Inc. | 2037 |
27 |
Pfizer Inc. | 3381 |
26 |
Takeda Pharmaceutical Company Limited | 2709 |
26 |
Shenzhen HighTide Biopharmaceutical, Ltd. | 57 |
26 |
Bayer AG | 3331 |
25 |
Pliant Therapeutics, Inc. | 65 |
25 |
Genentech, Inc. | 3980 |
23 |
Merck Sharp & Dohme Corp. | 2190 |
22 |
Glaxosmithkline Intellectual Property Development Limited | 761 |
22 |
Other owners | 2988 |